跳至主要内容
临床试验/NCT07738731
NCT07738731尚未招募不适用

A Randomized Controlled Study of Dialysis Less Frequently in the Elderly

Queen's University10 个研究点 分布在 1 个国家目标入组 210 人开始时间: 2026年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
210
试验地点
10
主要终点
Days Alive and Out of Hospital

研究概览

简要总结

Many people who have kidney failure require hemodialysis treatments to stay alive. Hemodialysis is a procedure that cleans the blood of the toxins and fluids that build up when kidneys don't work. Most patients receive hemodialysis treatment three times every week and each treatment lasts 4 hours. These patients spend 156 days per year receiving hemodialysis treatments. This is a very large time burden which has a tremendous impact on well-being and life satisfaction. Current usual approach of prescribing three hemodialysis treatments per week is not based on good studies and assumes that all people need the same number of hemodialysis treatments per week regardless of their age, values, life expectancy or other health conditions. Over time, increasingly more elderly people are needing to start hemodialysis treatments. The investigators have conducted a preliminary study that shows that patients who are 70 years of age or older can do well when only receiving only two hemodialysis treatments per week. In this preliminary study, receiving two hemodialysis treatments per week was no different than three hemodialysis treatments per week with regards to important safety measures including blood values and management of body fluid levels. The investigators now propose to carry out a much larger study in many centers across Canada that will compare two times per week hemodialysis treatments to three times per week hemodialysis treatments in elderly patients who have reached kidney failure and are beginning their hemodialysis journey. The investigators want to know if receiving hemodialysis treatments twice per week increases the number of days that a patient is able to spend at home without increasing rates of hospitalization or death compared to receiving hemodialysis treatments three times per week. The investigators also want to know if this is better for people's quality of life, safe, less expensive for the health care system and friendlier to the environment. The results of this study will help elderly patients needing to start hemodialysis treatments, medical care teams who help make decisions about how many hemodialysis treatments per week are necessary as well as kidney organizations that oversee kidney care for patients in Canada and around the world.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
70 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients aged 70 or above
  • have developed end stage kidney disease and require hemodialysis treatment

排除标准

  • Hospitalized patients without an alternate level of care designation
  • Those with missed hemodialysis sessions due to non-adherence during the first 7 weeks of hemodialysis treatment
  • Patients already prescribed twice weekly hemodialysis
  • Patients who are medically unsuitable as per primary care team and site investigator
  • anticipated significant barriers to ascertainment of patient-reported experience measures

结局指标

主要结局

Days Alive and Out of Hospital

时间窗: 365 days

Days Alive and Out of Hospital is an important patient-centered goal and outcome that approximates time spent at home.

次要结局

  • Days Alive and Out of Hospital(2 years)
  • Quality-adjusted life years(2 years)
  • Change in Edmonton Symptom Assessment Scale-revised Renal score from baseline to average of all follow-up assessments(2 years)
  • Change in Kidney Dialysis and Quality of Life-36 scores from baseline to average of all follow-up assessments(2 years)
  • Clinical Frailty Scale score(2 years)
  • Number of urgent unscheduled hemodialysis treatment for hyperkalemia(2 years)
  • Number of urgent unscheduled hemodialysis treatment for volume overload(2 years)
  • Weekly pre-hemodialysis potassium levels > 5.9 mmol/L(2 years)
  • Change in urine volume(2 years)
  • Hospitalization(2 years)
  • Kidney function recovery(2 years)
  • Elective withdrawal from hemodialysis treatment(2 years)
  • Cost(2 years)
  • Environmental costs attributed to hemodialysis treatment(2 years)
  • mortality(2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Christine White

Principal Investigator

Queen's University

研究点 (10)

Loading locations...

相似试验

Dialysis Less Frequently in the Elderly | 临床试验